Sarah L Nolin

Dr. Sarah L Nolin


Research Focus & Metrics

Academic Career Length

43Years (1984-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2003 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
SNSarah L Nolin
Sarah L Nolin
WBW. Ted Brown
W. Ted Brown
AGAnne Glicksman
Anne Glicksman
JHJr. George E. Houck
Jr. George E. Houck
AGAlice D. Gargano
Alice D. Gargano
SSStephanie L. Sherman
Stephanie L. Sherman

15 July 1994 in American Journal of Medical Genetics
Verified
Journal Article
Closed access
PDF file
SNSarah L Nolin
Sarah L Nolin
AGAnne Glicksman
Anne Glicksman
GHGeorge E. Houck
George E. Houck
WBW. Ted Brown
W. Ted Brown
CDCarl S. Dobkin
Carl S. Dobkin

1 May 2015 in Genetics in Medicine
Verified
Journal Article
Open access
PDF file
SNSarah L Nolin
Sarah L Nolin
AGAnne Glicksman
Anne Glicksman
NENicole Ersalesi
Nicole Ersalesi
CDCarl Dobkin
Carl Dobkin
WBW. Ted Brown
W. Ted Brown
AHAndrew G. Hadd
Andrew G. Hadd
Fragile X CGG repeat alleles often contain one or more AGG interruptions that influence allele stability and risk of a full mutation transmission from parent to child. We have examined transmissions of maternal and paternal alleles with 45–90 repeats to quantify the effect of AGG interruptions on fragile X repeat instability. A novel FMR1 polymerase chain reaction assay was used to determine CGG repeat length and AGG interruptions for 1,040 alleles from 705 families. We grouped transmissions into nine categories of five repeats by parental size and found that in every size category, alleles with no AGGs had the greatest risk for instability. For maternal alleles <75 repeats, 89% (24/27) that expanded to a full mutation had no AGGs. Two contractions in maternal transmission were accompanied by loss of AGGs, suggesting a mechanism for generating alleles that lack AGG interruptions. Maternal age was examined as a factor in full mutation expansions using prenatal samples to minimize ascertainment bias, and a possible effect was observed though it was not statistically significant (P = 0.06). These results strengthen the association of AGG repeats with CGG repeat stability and provide more accurate risk estimates of full mutation expansions for women with 45–90 repeat alleles. Genet Med 17 5, 358–364.

30 June 2011 in Prenatal Diagnosis
Verified
Journal Article
Open access
PDF file
SNSarah L Nolin
Sarah L Nolin
AGAnne Glicksman
Anne Glicksman
XDXiaohua Ding
Xiaohua Ding
NENicole Ersalesi
Nicole Ersalesi
WBW. Ted Brown
W. Ted Brown
CDCarl Dobkin
Carl Dobkin
Objective: To determine risks of expansion for normal, intermediate, and premutationFMR1CGG repeats.Methods: PCR was used to compare theFMR1alleles in prenatal (chorionic villi and amniocytes) and parental samples collected from 1991 to 2010. Prenatal diagnoses were confirmed by Southern analysis.Results: Fragile X analysis of 1112 pregnancies identified 558 normal, 106 intermediate, 216 premutation, and 232 full mutation fetuses. Of 509 maternal, intermediate, and premutation alleles, 350 (68.7%) were unstable on transmission with expansions ranging from one repeat to the full mutation. The smallest premutation alleles expanding to the full mutation were in mothers with 65 and 66 repeats. Transmissions from women with or without a family history of fragile X suggested greater instability in women from families that included full mutation expansions.Conclusions: The maternal transmissions of alleles with 55 to 59 CGG repeats summarized here indicate that the risk for expansion to full mutation is substantially less than previous estimates for this size category. Most premutation alleles with no family history of fragile X exhibited less instability than those with a history of fragile X. Thus, lower risk estimates for full mutation expansion may be appropriate for women newly identified as premutation carriers through routine screening. Copyright © 2011 John Wiley & Sons, Ltd.

26 February 2013 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
SNSarah L Nolin
Sarah L Nolin
SSSachin Sah
Sachin Sah
AGAnne Glicksman
Anne Glicksman
SSStephanie L. Sherman
Stephanie L. Sherman
EAEmily Allen
Emily Allen
AHAndrew G. Hadd
Andrew G. Hadd

1 May 2003 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
YSYing Ju Sung
Ying Ju Sung
NDNatalia Dolzhanskaya
Natalia Dolzhanskaya
SNSarah L Nolin
Sarah L Nolin
TBTed Brown
Ted Brown
JCJulia R. Currie
Julia R. Currie
RDRobert B. Denman
Robert B. Denman
Loss of the RNA-binding protein FMRP (fragile X mental retardation protein) leads to fragile X syndrome, the most common form of inherited mental retardation. Although some of the messenger RNA targets of this protein, including FMR1, have been ascertained, many have yet to be identified. We have found thatXenopus elongation factor 1A (EF-1A) mRNA binds tightly to recombinant human FMRP in vitro. Binding depended on protein determinants located primarily in the C-terminal end of hFMRP, but the hnRNP K homology domain influenced binding as well. When hFMRP was expressed in cultured cells, it dramatically reduced endogenous EF-1A protein expression but had no effect on EF-1A mRNA levels. In contrast, the translation of several other mRNAs, including those coding for dynamin and constitutive heat shock 70 protein, was not affected by the hFMRP expression. Most importantly, EF-1A mRNA and hFMR1 mRNA were coimmunoprecipitated with hFMRP. Finally, in fragile X lymphoblastoid cells in which hFMRP is absent, human EF-1A protein but not its corresponding mRNA is elevated compared with normal lymphoblastoid cells. These data suggest that hFMRP binds to EF-1A mRNA and also strongly argue that FMRP negatively regulates EF-1A expression in vivo.